Hypertrophic Cardiomyopathy Management

Hypertrophic Cardiomyopathy Management

What is it?

Hypertrophic cardiomyopathy is a genetic disorder in which the heart muscle thickens abnormally.  This primarily occurs in the wall (septum) that divides the two lower chambers of the heart (ventricles).  Blood flow in and out of the heart is blocked as a result and decreases the heart's ability to function.  Patients with hypertrophic cardiomyopathy are at risk of heart failure, heart rhythm disorders, or sudden death.

Several diagnostic tools may be used to evaluate hypertrophic cardiomyopathy, including cardiac catheterization techniques and advanced cardiovascular imaging techniques.  The condition has varying treatments, including medical management, ablation, device implantation, or cardiac surgery.  Hypertrophic cardiomyopathy is genetic. Our physicians may suggest that family members be tested to determine their risk of acquiring the condition.

The Loyola difference

Because Loyola is a leading academic medical center with access to advanced technology and clinical trials, its cardiomyopathy and heart failure patients often benefit from life-saving techniques and procedures that may not be available elsewhere. Our multidisciplinary team of cardiologists, cardiovascular surgeons, genetic counselors and other specialists have significant expertise in evaluation, diagnosis and treatment of this condition.

See Also

QUESTIONS?

Call (888) LUHS-888 to speak with a representative.

© 2011 Loyola University Chicago Health Sciences Division. All rights reserved.  &npsp; Privacy Policy   Privacy Policy